← Leaderboards
Ruibao Ren
Brandeis University
$3,904,240
Attributed
$3,904,240
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $373.3K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,904,240 · 3
By mechanism
R01$3,904,240 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseChronic Myelogenous LeukemiaNeoplasm /Cancer GeneticsColony Stimulating FactorTransfection /Expression VectorInterleukin 3Site Directed MutagenesisCarcinogenesisBone MarrowCell ProliferationGene MutationCellsCell TypeChimeric ProteinsGenesEnzymesComplexCell CommunicationEventCultured CellsCell MembraneBiologicalEnvironmentChromosome Translocation
Grant awards (13)
Ras signaling in leukemogenesis$346,500
R01 · FY2010 · HL · contact PI
Ras signaling in leukemogenesis$342,819
R01 · FY2009 · HL · contact PI
Ras signaling in leukemogenesis$17,453
R01 · FY2009 · HL · contact PI
Ras signaling in leukemogenesis$340,971
R01 · FY2008 · HL · contact PI
Ras signaling in leukemogenesis$341,132
R01 · FY2007 · HL · contact PI
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC$373,313
R01 · FY2005 · CA
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC$372,599
R01 · FY2004 · CA
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC$371,904
R01 · FY2003 · CA
REGULATION OF IMMUNOGLOBULIN GENE EXPRESSION IN B CELLS$289,690
R01 · FY2003 · GM
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC$369,579
R01 · FY2002 · CA
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC$342,324
R01 · FY2001 · CA
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC$10,625
R01 · FY2001 · CA
BCR-ABL TARGET IDENTIFICATION IN THE LEUKEMOGENIC PATHWA$385,331
R01 · FY2000 · CA